Gilead stops late-stage trial of blood cancer treatment

(Reuters) – Gilead Sciences Inc said on Friday it was stopping a late-stage trial of its blood cancer treatment following an analysis.

(Reporting by Sriparna Roy in Bengaluru; Editing by Vinay Dwivedi)